BMRN CIK: 1048477

BioMarin Pharmaceutical Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
305
FY22:
176
FY23:
159
FY24:
573
FY25:
828
Change from FY21 to FY25
millions USD
FY21:
−366
FY22:
−20.0
FY23:
−111
FY24:
136
FY25:
−414
Change from FY21 to FY25
millions USD
FY21:
−0.05
FY22:
−18.7
FY23:
−18.7
FY24:
−526
FY25:
−42.4
millions USD
FY21:
−61.9
FY22:
137
FY23:
30.6
FY24:
188
FY25:
369
(positive)
Change from FY21 to FY25
millions USD
FY21:
209
FY22:
54.9
FY23:
62.6
FY24:
487
FY25:
725

All amounts in millions USD Data source:SEC EDGAR